Tdap and Biomarkers of Alzheimer's Disease Clinical Trial
Posted: Sun Jan 23, 2022 4:56 am
I've been asked to post about a clinical trial that will attempt to evaluate the effect of the Tdap vaccination on AD biomarkers. You can read more about it here: Tdap and Biomarkers of Alzheimer's Disease
You must be 50 Years to 80 years old, cognitively normal (SAGE test >17). and immunocompetent.
CONTACT:
Alie Halverson (mindfuldt@gmail.com) for more information.
TO PARTICIPATE:Recently, the Tdap (tetanus toxoid, reduced diphtheria toxoid and acellular pertussis) vaccination was added to the list of immunizations associated with lower incidence of dementia. Plasma-based biomarkers for AD are a welcome alternative to expensive and invasive testing for Alzheimer's; these biomarkers include assessment of amyloid and tau and neurofilament light protein that assesses non-specific neurodegeneration. We will test for these biomarkers, as well as some immune parameters, administer Tdap then repeat the blood tests in six months.
You must be 50 Years to 80 years old, cognitively normal (SAGE test >17). and immunocompetent.
CONTACT:
Alie Halverson (mindfuldt@gmail.com) for more information.